Framework agreement for the supply of pharmaceutical products

Framework agreement for the supply of pharmaceutical products

This procurement exercise is intended to establish a framework agreement against which Public Health England would call off their requirements for either potassium iodate or potassium iodide tablets to be held in a stockpile of emergency medicines.

UK-Runcorn: Pharmaceutical products

2013/S 123-210519

Contract notice

Supplies

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

The Secretary of State for Health acting through the Commercial Medicines Unit (part of the Department of Health)
Castle View House, East Lane
For the attention of: Lynne Nichols
WA7 2AA Runcorn
UNITED KINGDOM
E-mail: lynne.nichols@cmu.nhs.uk

Further information can be obtained from: The above mentioned contact point(s)

Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)

Tenders or requests to participate must be sent to: The above mentioned contact point(s)

I.2)Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local sub-divisions
I.3)Main activity

Health
Other: Public Procurement
I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: yes

Section II: Object of the contract

II.1)Description
II.1.1)Title attributed to the contract by the contracting authority:

Framework agreement for the supply of thyroid blocking agents (potassium iodate or potassium iodide).
II.1.2)Type of contract and location of works, place of delivery or of performance

Supplies
Purchase
Main site or location of works, place of delivery or of performance: To a location in England to be notified to the successful bidder(s) following award to framework agreement.
NUTS code
II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)

The notice involves the establishment of a framework agreement
II.1.4)Information on framework agreement

Duration of the framework agreement

Duration in years: 4
Estimated total value of purchases for the entire duration of the framework agreement

Estimated value excluding VAT:
Range: between 6 000 000 and 20 000 000 GBP

II.1.5)Short description of the contract or purchase(s)

This procurement exercise is intended to establish a framework agreement against which Public Health England would call off their requirements for either potassium iodate or potassium iodide tablets to be held in a stockpile of emergency medicines.
Deliveries will be required over a period of 2 years, with an option to extend for up to a further 2 years.
II.1.6)Common procurement vocabulary (CPV)

33600000, 33690000, 33651000

II.1.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): yes
II.1.8)Lots

This contract is divided into lots: no
II.1.9)Information about variants

Variants will be accepted: no
II.2)Quantity or scope of the contract
II.2.1)Total quantity or scope:

Information will be contained within the Invitation to Offer
Estimated value excluding VAT:
Range: between 6 000 000 and 20 000 000 GBP
II.2.2)Information about options

Options: yes
Description of these options: Framework agreement has the option to be extended for a period of up to 24months
II.2.3)Information about renewals
II.3)Duration of the contract or time limit for completion

Starting 1.4.2014. Completion 31.3.2018

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Deposits and guarantees required:

Parent company or other guarantees may be required in certain circumstances.
Please refer to the PQQ evaluation approach document which can be accessed once you have expressed an interest within the Bravo portal under ‘Framework agreement for the supply of thyroid blocking agents’
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:

Information will be contained within the Invitation to Offer
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:

No special legal form is required but, if a contract is awarded to a consortium of economic operators, the members of that consortium may be required to form a legal entity before entering into a Framework Agreement and may be required to provide parent company or directors’ guarantees or, if not required to form a legal entity,members of a consortium may be required to accept joint and several liability both to the Contracting Authority under the Framework Agreement and to other contracting authorities awarding contracts under the Framework Agreement.
III.1.4)Other particular conditions

The performance of the contract is subject to particular conditions: yes
Description of particular conditions: Information will be contained within the Invitation to Offer
III.2)Conditions for participation
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers
III.2.2)Economic and financial ability

Information and formalities necessary for evaluating if the requirements are met: Please refer to the selection criteria contained in the PQQ
III.2.3)Technical capacity

Information and formalities necessary for evaluating if the requirements are met:
Please refer to the selection criteria contained in the PQQ
III.2.4)Information about reserved contracts
III.3)Conditions specific to services contracts
III.3.1)Information about a particular profession
III.3.2)Staff responsible for the execution of the service

Section IV: Procedure

IV.1)Type of procedure
IV.1.1)Type of procedure

Restricted
IV.1.2)Limitations on the number of operators who will be invited to tender or to participate
IV.1.3)Reduction of the number of operators during the negotiation or dialogue
IV.2)Award criteria
IV.2.1)Award criteria

The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document
IV.2.2)Information about electronic auction

An electronic auction will be used: no
IV.3)Administrative information
IV.3.1)File reference number attributed by the contracting authority:

CM/EMP/13/5405
IV.3.2)Previous publication(s) concerning the same contract

no
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document
IV.3.4)Time limit for receipt of tenders or requests to participate

25.7.2013 – 13:00
IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates

7.8.2013
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up

English.
IV.3.7)Minimum time frame during which the tenderer must maintain the tender

in days: 180 (from the date stated for receipt of tender)
IV.3.8)Conditions for opening of tenders

Section VI: Complementary information

VI.1)Information about recurrence
VI.2)Information about European Union funds
VI.3)Additional information

Any supplier may be disqualified who does not respond to the following in the requisite manner:
1) Submission of expression of interest and procurement specific information
This procurement exercise will be conducted on the eTendering portal at www.cmu.bravosolution.co.uk.

Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) If not already registered, Candidates should register on the eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:

— accept the terms and conditions and click continue,
— enter your correct business and user details,
— note the username you chose and click “Save” when complete,
— you will shortly receive an email with your unique password (please keep this secure).
1.2) Once registered, candidates must express interest as follows:
a. login to the eTendering portal;
b. select “Response to PQQ”;
c. select “PQQs Open To All Suppliers”;
d. access listing related to this procurement “Framework agreement for the supply of thyroid blocking agents” and view details;
e. click on “Express interest” button at the top of the page.
f. Once you have expressed interest, the PQQ will move to “My PQQs”, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the “Publish” button.
1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 800 368 4850 or help@bravosolution.co.uk.

2) General supplier information.
To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Governments supplier information database, sid4gov, as follows:
2.1) If not already registered, Candidates must go to the following web page https://sid4gov.cabinetoffice.gov.uk/ and select “Register for sid4gov” at the bottom of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on sid4gov.

2.2) Once registration is complete you are able to create and update your sid4gov company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.
2.3) For further help or information concerning sid4gov, please contact the sid4gov Helpdesk at: support@nqc.com or telephone +44 (0) 845 299 2994.

The framework agreement is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom and Crown Dependencies including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
Contracts awarded under a framework agreement may be awarded either: a) by application of the terms laid down in the framework agreement without reopening competition, or b) where not all the required terms of the proposed contracts are laid down in the framework agreement, by reopening competition between the economic operators which are parties to this framework agreement and which are capable of performing the proposed contract. Reopening of competition will be done in accordance with the procedure set out in Directive 2004/18/EC, Article 32.
Potential suppliers should note that, in accordance with the Government’s policies on transparency, the Contracting Authority intends to publish the OJEU, ITO and the text of final contracts / framework agreements, subject to possible redactions at the discretion of the CMU (part of the Department of Health). Further information on transparency can be found at: http://www.cabinetoffice.gov.uk/resource-library/guidance-transparency.

VI.4)Procedures for appeal
VI.4.1)Body responsible for appeal procedures
VI.4.2)Lodging of appeals
VI.4.3)Service from which information about the lodging of appeals may be obtained

VI.5)Date of dispatch of this notice:24.6.2013